Literature DB >> 20201807

Conformations and biological activities of amyloid beta peptide 25-35.

L Millucci1, L Ghezzi, G Bernardini, A Santucci.   

Abstract

Amyloid-beta (Abeta) peptide is commonly found in human Alzheimer's disease (AD) brain and is the main component of Alzheimer amyloid plaques. The predominant forms of Abeta in the human brain are Abeta(1-40) and Abeta(1-42), but Abeta(25-35) fragment, physiologically present in elderly people, is the more toxic region and has been recently found to play a relevant role in AD, due to its peculiar aggregation properties. In this work, we review the current understanding on the conformations and biological activity of Abeta(25-35) exploring aggregation, cytotoxic and neurodegenerative properties of this fundamental Abeta fragment, in order to provide an effective starting point to better approach a pathology spread and problematic as AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201807     DOI: 10.2174/138920310790274626

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  55 in total

1.  Sesaminol glucosides protect β-amyloid induced apoptotic cell death by regulating redox system in SK-N-SH cells.

Authors:  Min Young Um; Ji Yun Ahn; Mi Kyung Kim; Tae Youl Ha
Journal:  Neurochem Res       Date:  2011-12-06       Impact factor: 3.996

2.  Role of amyloid β in the induction of lipolysis and secretion of adipokines from human adipose tissue.

Authors:  Zhongxiao Wan; Dorrian Mah; Svetlana Simtchouk; Andreas Kluftinger; Jonathan P Little
Journal:  Adipocyte       Date:  2014-12-31       Impact factor: 4.534

3.  Sphingosine kinase-1 protects differentiated N2a cells against beta-amyloid25-35-induced neurotoxicity via the mitochondrial pathway.

Authors:  Yang Yang; Min Wang; Bingjie Lv; Rong Ma; Jing Hu; Yaoyan Dun; Shenggang Sun; Gang Li
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996

4.  Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).

Authors:  Guanghu Wang; Michael Dinkins; Qian He; Gu Zhu; Christophe Poirier; Andrew Campbell; Margot Mayer-Proschel; Erhard Bieberich
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

5.  Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides.

Authors:  Jacques Fantini; Coralie Di Scala; Nouara Yahi; Jean-Denis Troadec; Kevin Sadelli; Henri Chahinian; Nicolas Garmy
Journal:  ACS Chem Neurosci       Date:  2014-01-12       Impact factor: 4.418

6.  Role of β-hairpin formation in aggregation: the self-assembly of the amyloid-β(25-35) peptide.

Authors:  Luca Larini; Joan-Emma Shea
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

7.  A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules.

Authors:  Cyril J Craven
Journal:  Theor Biol Med Model       Date:  2014-09-14       Impact factor: 2.432

8.  Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats.

Authors:  Charleine Zussy; Anthony Brureau; Brice Delair; Stephane Marchal; Emeline Keller; Guy Ixart; Gaelle Naert; Johann Meunier; Nathalie Chevallier; Tangui Maurice; Laurent Givalois
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

9.  Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity.

Authors:  Mariza G Prado Lima; Helen L Schimidt; Alexandre Garcia; Letícia R Daré; Felipe P Carpes; Ivan Izquierdo; Pâmela B Mello-Carpes
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

10.  Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice.

Authors:  Sylvia E Perez; Muhammad Nadeem; Katherine R Sadleir; Joanna Matras; Christy M Kelley; Scott E Counts; Robert Vassar; Elliott J Mufson
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.